Exact Mass: 409.12493440000003

Exact Mass Matches: 409.12493440000003

Found 259 metabolites which its exact mass value is equals to given mass value 409.12493440000003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

linustatin

2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]propanenitrile

C16H27NO11 (409.15840319999995)

1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole

[(2R,3S,4R,5R)-5-[5-amino-4-[(4-amino-4-oxo-butanoyl)amino]imidazol-1-yl]-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate

C12H20N5O9P (409.0998600000001)

DU-6859

SITAFLOXACINISOMER?(RSR)

C19H18ClF2N3O3 (409.1004692)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

SN-38 carboxylate form

C22H21N2O6- (409.1399546)

PF-670462

4-(1-cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyrimidin-2-amine dihydrochloride

C19H22Cl2FN5 (409.1236204)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

IWR-1-endo

4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide

C25H19N3O3 (409.1426344)

Ezetimibe

(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Ezetimibe is an anti-hyperlipidemic medication which is used to lower cholesterol levels. Specifically, it appears to bind to a critical mediator of cholesterol absorption, the Niemann-Pick C1-Like 1 (NPC1L1) protein on the gastrointestinal tract epithelial cells as well as in hepatocytes. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

Queuosine

2-amino-7-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-1H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

Queuosine is a modified nucleoside that is present in certain tRNAs in bacteria and eukaryotes. Originally identified in E. coli, queuosine was found to occupy the first anticodon position of tRNAs for histidine, aspartic acid, asparagine and tyrosine. The first anticodon position pairs with the third "wobble" position in codons, and queuosine improves accuracy of translation. Synthesis of queuosine begins with GTP. In bacteria, two classes of riboswitch are known to regulate genes that are involved in the synthesis or transport of pre-queuosine1, a precursor to queuosine: PreQ1-I riboswitches and PreQ1-II riboswitches (Wikipedia). Queuosine is a modified nucleoside that is present in certain tRNAs in bacteria and eukaryotes. Originally identified in E. coli, queuosine was found to occupy the first anticodon position of tRNAs for histidine, aspartic acid, asparagine and tyrosine. The first anticodon position pairs with the third "wobble" position in codons, and queuosine improves accuracy of translation. Synthesis of queuosine begins with GTP. In bacteria, two classes of riboswitch are known to regulate genes that are involved in the synthesis or transport of pre-queuosine1, a precursor to queuosine: PreQ1-I riboswitches and PreQ1-II riboswitches.

Q

(2R,3R,4S,5R)-2-[5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-4-hydroxy-2-imino-1H,2H,7H-pyrrolo[2,3-d]pyrimidin-7-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C17H23N5O7 (409.1597408)

Q is part of the Oxidative phosphorylation, Cardiac muscle contraction, Alzheimers disease, Parkinsons disease, and Huntingtons disease pathways. It is a substrate for: Cytochrome b-c1 complex subunit Rieske, mitochondrial.

Chondroitin D-glucuronate

(2S,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)

This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

dermatan L-iduronate

(2R,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)

This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

N-Carbamoyl glucuronide lorcaserin

(2R,3R,4R,5S)-6-(8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-3-carbonyloxy)-3,4,5-trimethyloxane-2-carboxylic acid

C21H28ClNO5 (409.1655908000001)

N-Carbamoyl glucuronide lorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

Urea,3,4-tri-O-acetyl-D-ribopyranosyl)-

4,5-Bis(acetyloxy)-2-[N-(2-chloroethyl)-N-nitroso-(C-hydroxycarbonimidoyl)amino]oxan-3-yl acetic acid

C14H20ClN3O9 (409.088802)

Acetylcorynoline

13,24-Dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetic acid

C23H23NO6 (409.1525298)

N-((6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-proline

1-(2-{[hydroxy(5-hydroxy-6-methyl-3,6-dihydro-2H-1,4-thiazin-3-yl)methylidene]amino}-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-2-carboxylate

C17H23N5O5S (409.14198280000005)

8-(2,4-Dichlorophenyl)-N-(1,3-dimethoxypropan-2-yl)-2,7-dimethylpyrazolo[5,1-f][1,3,5]triazin-4-amine

8-(2,4-dichlorophenyl)-N-(1,3-dimethoxypropan-2-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine

C18H21Cl2N5O2 (409.1072226)

7-[(7S)-7-Amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid

7-{7-amino-5-azaspiro[2.4]heptan-5-yl}-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C19H18ClF2N3O3 (409.1004692)

Lifibrate

1-Methylpiperidin-4-yl 2,2-bis(4-chlorophenoxy)acetic acid

C20H21Cl2NO4 (409.08475660000005)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

methionine aspartate aspartate

4,11-diamino-3,6,9,12-tetraoxo-1,2,7,8-tetraoxacyclododecan-4-yl 2-amino-4-(methylsulfanyl)butanoate

C13H19N3O10S (409.0791114)

Piclozotan

3-chloro-4-(4-{1,2,3,6-tetrahydro-[2,4-bipyridine]-1-yl}butyl)-4,5-dihydro-1,4-benzoxazepin-5-one

C23H24ClN3O2 (409.1556954)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Telatinib

4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methylpyridine-2-carboxamide

C20H16ClN5O3 (409.0941616)

Trifluperidol

1-(4-fluorophenyl)-4-{4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl}butan-1-one

C22H23F4NO2 (409.1664826)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Verubecestat

N-[3-(3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl]-5-fluoropyridine-2-carboxamide

C17H17F2N5O3S (409.1020116000001)

Linustatin

2-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-methylpropanenitrile

C16H27NO11 (409.15840319999995)

Linustatin is a member of the class of compounds known as cyanogenic glycosides. Cyanogenic glycosides are glycosides in which the aglycone moiety contains a cyanide group. Linustatin is soluble (in water) and a very weakly acidic compound (based on its pKa). Linustatin can be found in a number of food items such as broad bean, plains prickly pear, shea tree, and longan, which makes linustatin a potential biomarker for the consumption of these food products.

Acetylcorynoline

[(1R,12S,13R)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl] acetate

C23H23NO6 (409.1525298)

Acetylcorynoline is a benzophenanthridine alkaloid. Acetylcorynoline is a natural product found in Corydalis bungeana, Corydalis remota, and other organisms with data available. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1]. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1].

[Chemical] Source; sea squirt H-antigen (limited periodate oxide)

Fluoxetine Succinamic Acid

C21H22F3NO4 (409.15008480000006)

CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 702

6,7-dimethoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Macarpin

C22H19NO7 (409.11614640000005)

8-Ethoxy-3-oxo-1,2-dehydroretrorsine

C20H27NO8 (409.17365820000003)

cladoniamide D

C21H16ClN3O4 (409.08292860000006)

An organic heteropentacyclic compound that is cladoniamide E in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

FT-0689398

C23H23NO6 (409.1525298)

eudistomidin H

C22H24BrN3 (409.1153484)

eudistomidin I

C22H24BrN3 (409.1153484)

conithiaquinone B

C20H27NO6S (409.1559002000001)

Citropone B

C23H23NO6 (409.1525298)

Fibrostatin E

C18H19NO8S (409.0831334)

(-)-ethyl (reframidin-15-yl)acetate

C23H23NO6 (409.1525298)

cladoniamide F

C21H16ClN3O4 (409.08292860000006)

An organic heteropentacyclic compound that is cladoniamide G in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

Fibrostatin D

C18H19NO8S (409.0831334)

2,3,5-Tri-O-acetylguanosine

C16H19N5O8 (409.1233574)

2-amino-5-[(4,5-dihydroxy-cyclopent-2-enylamino)-methyl]-7-Beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

parazoanthine D

C16H20BrN5O3 (409.0749430000001)

Pro Met Tyr

C19H27N3O5S (409.1671332)

Phe Asp Glu

C18H23N3O8 (409.1485078)

Glu Phe Asp

C18H23N3O8 (409.1485078)

Asn Asn Tyr

C17H23N5O7 (409.1597408)

Asp Glu Phe

C18H23N3O8 (409.1485078)

Asp Phe Glu

C18H23N3O8 (409.1485078)

Asn Tyr Asn

C17H23N5O7 (409.1597408)

Phe Glu Asp

C18H23N3O8 (409.1485078)

Met Pro Tyr

C19H27N3O5S (409.1671332)

Glu Asp Phe

C18H23N3O8 (409.1485078)

Met Glu Met

C15H27N3O6S2 (409.1341202)

Pro Tyr Met

C19H27N3O5S (409.1671332)

Hyaluronic acid

C16H27NO11 (409.15840319999995)

MLS002153367-01!Dehydroisoandrosterone 3-sulfate sodium salt dihydrate1099-87-2

[C19H30NaO6S]+ (409.16607000000005)

MLS001332601-01!Dehydroisoandrosterone 3-sulfate sodium salt dihydrate1099-87-2

C19H30NaO6S (409.16607000000005)

Ezetimibe

C24H21F2NO3 (409.14894200000003)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

Ala Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H23N5O6S2 (409.1089698)

Ala Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Ala Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Ala Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C14H27N5O5S2 (409.1453532)

Cys Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

C13H23N5O6S2 (409.1089698)

Cys Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Cys Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

C13H23N5O6S2 (409.1089698)

Cys Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

C13H23N5O6S2 (409.1089698)

Cys Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)

Cys Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C13H23N5O6S2 (409.1089698)

Cys Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Cys Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Cys Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Cys Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

C13H23N5O6S2 (409.1089698)

Cys Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Cys Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

C13H23N5O6S2 (409.1089698)

Cys Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Cys Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Cys Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8S (409.1267278)

Gly Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)

Gly Cys Cys Gln

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C13H23N5O6S2 (409.1089698)

Gly Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Gly Cys Gln Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Gly Gly Asn Tyr

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Gly Gly Tyr Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Gly Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Gly Asn Gly Tyr

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Gly Asn Tyr Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C17H23N5O7 (409.1597408)

Gly Gln Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Gly Tyr Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Gly Tyr Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetic acid

C17H23N5O7 (409.1597408)

Tyr Pro Met

C19H27N3O5S1 (409.1671332)

Pro Tyr Met

C19H27N3O5S1 (409.1671332)

Lys Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Lys Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Lys Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Met Pro Tyr

C19H27N3O5S1 (409.1671332)

Asn Ala Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Asn Cys Ala Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Asn Cys Cys Ala

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C13H23N5O6S2 (409.1089698)

Asn Cys Ser Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Asn Gly Gly Tyr

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Asn Gly Tyr Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]acetic acid

C17H23N5O7 (409.1597408)

Glu Met Met

C15H27N3O6S2 (409.1341202)

Asn Ser Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Asn Ser Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C13H23N5O8S (409.1267278)

Asn Tyr Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetic acid

C17H23N5O7 (409.1597408)

Gln Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C13H23N5O6S2 (409.1089698)

Gln Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Tyr Met Pro

C19H27N3O5S1 (409.1671332)

Gln Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S2 (409.1089698)

Met Tyr Pro

C19H27N3O5S1 (409.1671332)

Tyr Asn Asn

C17H23N5O7 (409.1597408)

Ser Cys Asn Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Ser Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O8S (409.1267278)

Ser Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C13H23N5O8S (409.1267278)

Ser Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C13H23N5O8S (409.1267278)

Pro Met Tyr

C19H27N3O5S1 (409.1671332)

Ser Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H23N5O8S (409.1267278)

Ser Ser Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O8S (409.1267278)

Met Met Glu

C15H27N3O6S2 (409.1341202)

Tyr Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Tyr Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C17H23N5O7 (409.1597408)

Tyr Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C17H23N5O7 (409.1597408)

IWR-1-exo

4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide

C25H19N3O3 (409.1426344)

Queuosine

(7-(((4,5-cis-Dihydroxy-2-cyclopenten-1-yl)amino)methyl)-7-deazaguanosine)

C17H23N5O7 (409.1597408)

Thioridazine-d3 (hydrochloride)

C21H24ClD3N2S2 (409.149240734)

(R)-2-Benzyloxycarbonylamino-1,5-dimethanesulfonyloxypentane

C15H23NO8S2 (409.0865038)

Fmoc-Glu-Oall

C23H23NO6 (409.1525298)

Pyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione,9-[(4-fluorophenyl)methyl]-6-hydroxy-1,3-dimethyl-7-(2-propynyl)- (9CI)

C20H16FN5O4 (409.1186268)

Thiazolidine, 3-[(2,3-dihydro-1H-phenalen-4-yl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C23H23NO2S2 (409.1170138)

Z-Ala-Trp-OH

C22H23N3O5 (409.16376280000003)

Diclofenac Epolamine

C21H25Cl2NO3 (409.12113999999997)

Tamsulosin Sulfonic Acid

C20H27NO6S (409.1559002000001)

(S)-(-)1 2 3 4-TETRAHYDRO-6 7DI-MEO-3-I&

C19H23NO7S (409.11951680000004)

glimepiride related compound c (20 mg) (glimepiride urethane)

C18H23N3O6S (409.13074980000005)

2-(METHYLAMINO)-2-PHENYLBUTYL 3,4,5-TRIMETHOXYBENZOATE HYDROCHLORIDE

C21H28ClNO5 (409.1655908000001)

Biclofibrate

C20H21Cl2NO4 (409.08475660000005)

Ezetimibe Tetrahydropyran Impurity

C24H21F2NO3 (409.14894200000003)

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-phenylmethoxyquinazolin-4-amine

C22H17ClFN3O2 (409.0993264)

Boc-D-His(tos)-OH

C18H23N3O6S (409.13074980000005)

Fmoc-Glu(Oall)-OH

C23H23NO6 (409.1525298)

(R)-Ezetimibe

C24H21F2NO3 (409.14894200000003)

m-Fluoro Prasugrel Hydrochloride

C20H21ClFNO3S (409.09146380000004)

p-Fluoro Prasugrel Hydrochloride

C20H21ClFNO3S (409.09146380000004)

Boc-His(Tos)-OH

C18H23N3O6S (409.13074980000005)

5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide

C18H20ClN3O4S (409.0862990000001)

10-hydroxy-9-nitrocamptothecin

C20H15N3O7 (409.090996)

1-tritylpyridin-1-ium,tetrafluoroborate

C24H20BF4N (409.1624838)

Eniclobrate

C24H24ClNO3 (409.14446240000007)

2,3,5-Triacetylguanosine

C16H19N5O8 (409.1233574)

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, 4-bromo-N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

C19H32BrN3Si (409.1548732)

2-(TRIBUTYLSTANNYL)BENZOXAZOLE

C19H31NOSn (409.1427506)

Sitafloxacin

7-[(7r)-7-Amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1s,2r)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

C19H18ClF2N3O3 (409.1004692)

[2-(diethylcarbamoyl)-4-(2,4-difluorophenyl)phenyl] benzoate

C24H21F2NO3 (409.14894200000003)

Prasugrel hydrochloride

C20H21ClFNO3S (409.09146380000004)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Prasugrel hydrochloride (PCR 4099 hydrochloride), a thienopyridine and proagent, inhibits platelet function. Prasugrel hydrochloride is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[1].

Sitafloxacin isomer I (SSR)

C19H18ClF2N3O3 (409.1004692)

(2,4-DIFLUORO-PHENYL)-[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-ACETIC ACID

C23H17F2NO4 (409.11255860000006)

BENZOSALICYLANILIDE GAMMA-PHENYLBUTYRATE

C27H23NO3 (409.16778480000005)

2-(METHYLAMINO)-2-PHENYLBUTYL 3,4,5-TRIMETHOXYBENZOATE

C21H28ClNO5 (409.1655908000001)

1H-Indazole-1-acetamide,N-(6-acetyl-1,3-benzodioxol-5-yl)-4,5,6,7-tetrahydro-3-(trifluoromethyl)-(9CI)

C19H18F3N3O4 (409.12493440000003)

Telatinib

C20H16ClN5O3 (409.0941616)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

fmoc-3-amino-2-naphthoic acid

C26H19NO4 (409.1314014000001)

TUNGSTEN(V) ETHOXIDE

C10H25O5W (409.12114299999996)

[(2S)-2-(dibenzylamino)-3-phenylpropyl] methanesulfonate

C24H27NO3S (409.17115520000004)

Pimethixene maleate

C23H23NO4S (409.13477180000007)

Pimethixene maleate is antihistamine and antiserotonergic compound, acts as an antimigraine agent. Pimethixene maleate is a highly potent antagonist of 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors, with pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively[1].

Reboxetine mesylate

Reboxetine (mesylate)

C20H27NO6S (409.1559002000001)

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators Reboxetine mesylate (FCE20124 mesylate) is a potent, selective, and specific noradrenaline reuptake inhibitor (NARI) for the research of depression. Reboxetine mesylate inhibits the uptake of norepinephrine, with a Ki of 8 nM[1].

(3S)-ent-Ezetimibe

C24H21F2NO3 (409.14894200000003)

ent-Ezetimibe

C24H21F2NO3 (409.14894200000003)

ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent?Nrf2 activator[1].

MK-8931

Verubecestat

C17H17F2N5O3S (409.1020116000001)

C26170 - Protective Agent > C1509 - Neuroprotective Agent C471 - Enzyme Inhibitor

C24H21F2NO3

C24H21F2NO3 (409.14894200000003)

Ezetimibe 3-Fluoro Impurity

C24H21F2NO3 (409.14894200000003)

C22H22F3NO.HCl

C22H22F3NO.HCl (409.14201740000004)

9,9-(2,6-pyridinediyl)bis-9H-carbazole

C29H19N3 (409.15788940000004)

2(1H)-Isoquinolinecarboxylic acid, 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-, 1,1-dimethylethyl ester

C22H23N3O3S (409.1460048)

Balovaptan

C22H24ClN5O (409.1669284)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

1,3-dimethyl-1,1,3,3-tetraphenyldisilazane

C26H27NSi2 (409.1681942)

(S)-5-Chloro-(cyclopropylethynyl)-2-[(4-methoxyphenyl)methyl]amion trifluoromethyl benzenemethanol

C21H19ClF3NO2 (409.10563400000007)

Cerlapirdine

C22H23N3O3S (409.1460048)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Cerlapirdine (SAM-531, PF-05212365) is a selective and potent full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine has the potential for researching the Alzheimer's disease[1].

PF-04418948

C23H20FNO5 (409.13254420000004)

Rabeximod

C22H24ClN5O (409.1669284)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

[4,5-Diacetyloxy-6-[[2-chloroethyl(nitroso)carbamoyl]amino]oxan-3-yl] acetate

C14H20ClN3O9 (409.088802)

trans-1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

4,5-Dimethyl-2-[[1-oxo-2-[4-(phenylmethyl)-1-pyridin-1-iumyl]ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

C23H25N2O3S+ (409.15858000000003)

N-[(6-Butoxynaphthalen-2-Yl)sulfonyl]-D-Glutamic Acid

C19H23NO7S (409.11951680000004)

N-[(6-Butoxynaphthalen-2-Yl)sulfonyl]-L-Glutamic Acid

C19H23NO7S (409.11951680000004)

N-[4-({[5-(Dimethylamino)-1-Naphthyl]sulfonyl}amino)butyl]-3-Sulfanylpropanamide

C19H27N3O3S2 (409.14937519999995)

3-[3-[[(2S)-2,3-dihydroxypropyl]amino]phenyl]-4-(5-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione

C22H20FN3O4 (409.14377720000005)

lifibrate

C20H21Cl2NO4 (409.08475660000005)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

2-amino-5-[[[(4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino]methyl]-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Aklaviketone(1-)

C22H17O8- (409.0923382)

A phenolate anion obtained by deprotonation of 5-hydroxy group of aklaviketone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

Methyl aklanonate(1-)

C22H17O8- (409.0923382)

N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-4-pentynamide

C22H23N3OS2 (409.1282468)

Dnp-Pro-Gln

C16H19N5O8 (409.1233574)

N-(1,3-benzodioxol-5-yl)-2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio]acetamide

C19H15N5O4S (409.08447100000006)

2,4-dihydroxy-N-((1E)-{4-methoxy-3-[(pyridin-2-ylthio)methyl]phenyl}methylene)benzohydrazide

C21H19N3O4S (409.1096214000001)

4-(2,5-dimethoxyphenyl)-3-[3-(4-methoxyphenyl)-1H-pyrazol-5-yl]-1H-1,2,4-triazole-5-thione

C20H19N5O3S (409.1208544000001)

1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide

C18H20ClN3O4S (409.0862990000001)

2-(4-Chloro-3-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester

C23H20ClNO4 (409.1080790000001)

2-(4-Chloro-2-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester

C23H20ClNO4 (409.1080790000001)

2-[[3-cyano-6-(3,4-dimethoxyphenyl)-2-pyridinyl]thio]-N-(2-furanylmethyl)acetamide

C21H19N3O4S (409.1096214000001)

7-(5-chloro-2-methoxyanilino)-6-[(4-methoxyphenyl)methyl]-7H-pyrrolo[3,4-b]pyridin-5-one

C22H20ClN3O3 (409.11931200000004)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-2,5-dioxo-4-(2-phenylethyl)-1-imidazolidinyl]acetamide

C22H23N3O5 (409.16376280000003)

(2-Methyl-[1,3]dioxolan-2-yl)-acetic acid [1-(3,4-dichloro-phenyl)-2,5-dimethyl-1H-pyrrol-3-ylmethylene]-hydrazide

C19H21Cl2N3O3 (409.09598960000005)

Orlandin anion

C22H17O8- (409.0923382)

desertorin A anion

C22H17O8- (409.0923382)

Glu-Asp-Phe

C18H23N3O8 (409.1485078)

Tyr-Asn-Asn

C17H23N5O7 (409.1597408)

Asn-Tyr-Asn

C17H23N5O7 (409.1597408)

Asp-Phe-Glu

C18H23N3O8 (409.1485078)

(S)-prasugrel hydrochloride

C20H21ClFNO3S (409.09146380000004)

2-cyclopropyl-2-hydroxy-6-mercapto-3-(3-methyl-1-pyridin-1-iumyl)-4-(4-nitrophenyl)-3,4-dihydro-1H-pyridine-5-carbonitrile

C21H21N4O3S+ (409.1334296)

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(4-thiazolyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide

C19H27N3O5S (409.1671332)

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(4-thiazolyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide

C19H27N3O5S (409.1671332)

Asp-Glu-Phe

C18H23N3O8 (409.1485078)

Glu-Phe-Asp

C18H23N3O8 (409.1485078)

Met-Tyr-Pro

C19H27N3O5S (409.1671332)

Pro-Tyr-Met

C19H27N3O5S (409.1671332)

Phe-Glu-Asp

C18H23N3O8 (409.1485078)

Glu-Met-Met

C15H27N3O6S2 (409.1341202)

Asn-Asn-Tyr

C17H23N5O7 (409.1597408)

Met-Glu-Met

C15H27N3O6S2 (409.1341202)

Met-Met-Glu

C15H27N3O6S2 (409.1341202)

Met-Pro-Tyr

C19H27N3O5S (409.1671332)

Phe-Asp-Glu

C18H23N3O8 (409.1485078)

Pro-Met-Tyr

C19H27N3O5S (409.1671332)

Tyr-Met-Pro

C19H27N3O5S (409.1671332)

Tyr-Pro-Met

C19H27N3O5S (409.1671332)

(R)-prasugrel hydrochloride

C20H21ClFNO3S (409.09146380000004)

4-(Furan-2-carbonyl)-1-(5-methyl-1,3,4-thiadiazol-2-yl)-5-(4-propan-2-ylphenyl)pyrrolidine-2,3-dione

C21H19N3O4S (409.1096214000001)

4-(2,3-Dihydro-1,4-benzodioxine-6-carbonyl)-1-[2-(dimethylamino)ethyl]-5-pyridin-2-ylpyrrolidine-2,3-dione

C22H23N3O5 (409.16376280000003)

Dehydroisoandrosterone 3-sulfate sodium salt dihydrate

C19H30NaO6S+ (409.16607000000005)

2,4-Dibenzyl-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,4H)-trione

C25H19N3O3 (409.1426344)

N-Carbamoyl glucuronide lorcaserin

C21H28ClNO5 (409.1655908000001)

Dermatan L-iduronate

C16H27NO11 (409.15840319999995)

SN-38 carboxylate

C22H21N2O6 (409.1399546)

A hydroxy monocarboxylic acid anion that is the conjugate base of SN-38 carboxylic acid, obtained from the deprotonation of the carboxy group. It is the major microspecies at pH 7.3.

orlandin(1-)

C22H17O8 (409.0923382)

A phenolate anion resulting from the deprotonation of the 7-hydroxy group orlandin. It is the major microspecies at pH 7.3.

desertorin A(1-)

C22H17O8 (409.0923382)

A phenolate anion that is the conjugate base of desertorin A, obtained by deprotonation of 7-hydroxy group of desertorin A. It is the major microspecies at pH 7.3.

SN-38

C22H21N2O6 (409.1399546)

LPC 8:3;O2

C16H28NO9P (409.15016080000004)

ST 18:3;O6;Gly

C20H27NO8 (409.17365820000003)

ST 18:4;O3;Tau

C20H27NO6S (409.1559002000001)

AT7867 (dihydrochloride)

C20H22Cl3N3 (409.08792220000004)

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.

FT113

C22H20FN3O4 (409.14377720000005)

FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM). FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo[1].

(23s)-11,12-dimethoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-ol

C22H19NO7 (409.11614640000005)

11-hydroxy-7-(1-hydroxyethylidene)-3-methoxy-5-methyl-4-(3-methylbut-2-en-1-yl)cyclohepta[b]quinoline-1,6,8-trione

C23H23NO6 (409.1525298)